Epidemiologist Behind Highly-Cited Coronavirus Model Drastically Wrong

Translate to Spanish or other 102 languages!

If her model is accurate, fewer than one in a thousand who’ve been infected with COVID-19 become sick enough to need hospitalization, leaving the vast majority with mild cases or free of symptoms. In other words, Ferguson’s highly influential initial model was off by orders of magnitude.
If her model is accurate, fewer than one in a thousand who’ve been infected with COVID-19 become sick enough to need hospitalization, leaving the vast majority with mild cases or free of symptoms. In other words, Ferguson’s highly influential initial model was off by orders of magnitude.

Mega Doctor News

- Advertisement -

By Amanda Prestigiacomo, Dailywire.com

Epidemiologist Neil Ferguson, who created the highly-cited Imperial College London coronavirus model, which has been cited by organizations like The New York Times and has been instrumental in governmental policy decision-making, offered a massive revision to his model on Wednesday.


Mega Doctor News a bilingual newspaper reaching your audience: Advertise with us!


Ferguson’s model projected 2.2 million dead people in the United States and 500,000 in the U.K. from COVID-19 if no action were taken to slow the virus and blunt its curve.

- Advertisement -

However, after just one day of ordered lockdowns in the U.K., Ferguson is presenting drastically downgraded estimates, revealing that far more people likely have the virus than his team figured. Now, the epidemiologist predicts, hospitals will be just fine taking on COVID-19 patients and estimates 20,000 or far fewer people will die from the virus itself or from its agitation of other ailments, as reported by New Scientist Wednesday.

Ferguson thus dropped his prediction from 500,000 dead to 20,000.

Author and former New York Times reporter Alex Berenson broke down the bombshell report via Twitter on Thursday morning (view Twitter thread below).

“This is a remarkable turn from Neil Ferguson, who led the [Imperial College] authors who warned of 500,000 UK deaths — and who has now himself tested positive for #COVID,” started Berenson. 

- Advertisement -

“He now says both that the U.K. should have enough ICU beds and that the coronavirus will probably kill under 20,000 people in the U.K. — more than 1/2 of whom would have died by the end of the year in any case [because] they were so old and sick,” he wrote.

Read more, click on the link below:

https://www.dailywire.com/news/epidemiologist-behind-highly-cited-coronavirus-model-admits-he-was-wrong-drastically-revises-model

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

VIDA Secures $300,000 to Boost Evidence-Based Mental Health Support for Students

Valley Initiative for Development and Advancement (VIDA) has been awarded a $300,000, two-year grant from Methodist Healthcare Ministries of South Texas, Inc. to launch an innovative initiative that integrates evidence-based mental health support into workforce development, strengthening student persistence and expanding access to care for underserved communities across the Rio Grande Valley.

DHR Health Offers Advanced, Comprehensive Care for Scoliosis Patients–Early Detection is Key!

In recognition of “National Scoliosis Awareness Month” in June, DHR Health is reminding the community that comprehensive scoliosis care is available close to home through its Scoliosis Rehabilitation Clinic and Orthopedic Spine Center of Excellence.

Teaming Up to Deliver Blankets and Comfort to Cancer Patients at DHR Health

Bert Ogden Subaru, in partnership with the Blood Cancer United, recently brought comfort and encouragement to patients receiving care at DHR Health’s Oncology Institute by presenting blankets and heart-shaped pillows to individuals courageously battling cancer.

Mayo Clinic Researchers Crack Key Code in Cancer Immune Response

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies.
- Advertisement -